Cargando…
5-Demethylnobiletin Inhibits Cell Proliferation, Downregulates ID1 Expression, Modulates the NF-κB/TNF-α Pathway and Exerts Antileukemic Effects in AML Cells
Acute myeloid leukemia (AML) is characterized by the dysregulation of hematopoietic cell proliferation, resulting in the accumulation of immature myeloid cells in bone marrow. 5-Demethylnobiletin (5-demethyl NOB), a citrus 5-hydroxylated polymethoxyflavone, has been reported to exhibit various bioac...
Autores principales: | Chen, Pei-Yi, Wang, Chih-Yang, Tsao, En-Ci, Chen, Yu-Ting, Wu, Ming-Jiuan, Ho, Chi-Tang, Yen, Jui-Hung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266321/ https://www.ncbi.nlm.nih.gov/pubmed/35806401 http://dx.doi.org/10.3390/ijms23137392 |
Ejemplares similares
-
Azelaic Acid Exerts Antileukemic Activity in Acute Myeloid Leukemia
por: Pan, Yunbao, et al.
Publicado: (2017) -
Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML
por: Volk, Andrew, et al.
Publicado: (2014) -
Targeting lactate dehydrogenase A (LDHA) exerts antileukemic effects on T‐cell acute lymphoblastic leukemia
por: Yu, Haizhi, et al.
Publicado: (2020) -
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML
por: Pianigiani, Giulia, et al.
Publicado: (2022) -
Prognosis of older patients with newly diagnosed AML undergoing antileukemic therapy: A systematic review
por: Hao, Qiukui, et al.
Publicado: (2022)